Hardman Johnston Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-17,420
| Closed | -$1.74M | – | 79 |
|
|
2020
Q1 | $1.74M | Sell |
17,420
-18,700
| -52% | -$1.86M | 0.1% | 52 |
|
|
2019
Q4 | $5.39M | Hold |
36,120
| – | – | 0.22% | 49 |
|
|
2019
Q3 | $4.63M | Buy |
36,120
+2,410
| +7% | +$309K | 0.21% | 46 |
|
|
2019
Q2 | $4.81M | Buy |
33,710
+10,770
| +47% | +$1.54M | 0.21% | 46 |
|
|
2019
Q1 | $3.28M | Sell |
22,940
-11,930
| -34% | -$1.71M | 0.14% | 49 |
|
|
2018
Q4 | $4.32M | Hold |
34,870
| – | – | 0.22% | 46 |
|
|
2018
Q3 | $5.86M | Sell |
34,870
-240
| -0.7% | -$40.4K | 0.25% | 46 |
|
|
2018
Q2 | $6.05M | Sell |
35,110
-1,350
| -4% | -$233K | 0.26% | 45 |
|
|
2018
Q1 | $5.51M | Sell |
36,460
-1,340
| -4% | -$202K | 0.23% | 46 |
|
|
2017
Q4 | $5.09M | Sell |
37,800
-5,780
| -13% | -$778K | 0.22% | 47 |
|
|
2017
Q3 | $6.37M | Sell |
43,580
-610
| -1% | -$89.2K | 0.27% | 47 |
|
|
2017
Q2 | $6.87M | Sell |
44,190
-1,690
| -4% | -$263K | 0.3% | 51 |
|
|
2017
Q1 | $6.66M | Sell |
45,880
-260
| -0.6% | -$37.7K | 0.3% | 51 |
|
|
2016
Q4 | $5.03M | Hold |
46,140
| – | – | 0.25% | 52 |
|
|
2016
Q3 | $5.61M | Buy |
46,140
+580
| +1% | +$70.5K | 0.26% | 52 |
|
|
2016
Q2 | $6.44M | Buy |
45,560
+210
| +0.5% | +$29.7K | 0.33% | 53 |
|
|
2016
Q1 | $5.92M | Buy |
+45,350
| New | +$5.92M | 0.35% | 51 |
|